• Sab. Apr 11th, 2026

neurodegenerative disease

  • Home
  • California grants $7.4 million to advance gene-edited stem cell therapy for Friedreich’ s ataxia

California grants $7.4 million to advance gene-edited stem cell therapy for Friedreich’ s ataxia

The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia,…

Researchers identify potential link between retinal changes, Alzheimer’s disease

A team of scientists at the Indiana University School of Medicine has identified that an eye condition affecting the retina, the light-sensing tissue in the back of the eye, may…